Clinical characteristics of the 44 patients
| Patient characteristics . | Value . |
|---|---|
| Year of diagnosis | 1984-2002 |
| Median age, y (range) | 50 (29-71) |
| Sex (M:F) | 2:1 |
| FLIPI score | |
| 0-1, n (%) | 12 (27) |
| 2, n (%) | 17 (38) |
| 3-5, n (%) | 14 (32) |
| Transformation | |
| Histologic (DLBCL), n (%) | 19 (43) |
| Clinical, n (%) | 8 (18) |
| No transformation, n (%) | 17 (39) |
| Median observation time, mo (range) | |
| All 44 patients | 88 (10-294) |
| Patients alive at the end of follow up (n = 22) | 96 (68-294) |
| Dead patients (n = 22) | 68 (10-190) |
| Patients with transformation (n = 27) | 84 (11-190) |
| Patients with no transformation (n=17) | 97 (10-294) |
| Patient characteristics . | Value . |
|---|---|
| Year of diagnosis | 1984-2002 |
| Median age, y (range) | 50 (29-71) |
| Sex (M:F) | 2:1 |
| FLIPI score | |
| 0-1, n (%) | 12 (27) |
| 2, n (%) | 17 (38) |
| 3-5, n (%) | 14 (32) |
| Transformation | |
| Histologic (DLBCL), n (%) | 19 (43) |
| Clinical, n (%) | 8 (18) |
| No transformation, n (%) | 17 (39) |
| Median observation time, mo (range) | |
| All 44 patients | 88 (10-294) |
| Patients alive at the end of follow up (n = 22) | 96 (68-294) |
| Dead patients (n = 22) | 68 (10-190) |
| Patients with transformation (n = 27) | 84 (11-190) |
| Patients with no transformation (n=17) | 97 (10-294) |
FLIPI indicates Follicular Lymphoma International Prognostic Index; and DLCBL, diffuse large B-cell lymphoma.